9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more

CMD Bioscience, LLC
5 Science Park
New Haven, CT 06511

Phone: 203 298 4251
Fax: 203 795 0765
Website: http://www.cmdbioscience.com

Joseph Audie, Ph.D. - joseph.audie@cmdbioscience.com

General Information
CMD Bioscience is a Connecticut based company that employs cutting edge in silico methods to identify and optimize biologically and clinically important peptide and protein interactions. Using our proprietary computational methods we provide a range of services:

1. Peptide hit identification through high-throughput virtual screening

2. Peptide-to-peptidomimetic and peptide-to-small molecule optimization

3. Predict the water-lipid partitioning behavior of peptides and proteins

4. Predict and model protein and peptide interactions through docking

5. Identify the anchor residues at protein interfaces

6. Predict and model the effects of mutations at protein interfaces

A typically drug discover project, for example, might include a several rounds of peptide hit identification followed by several rounds of peptide-to-small molecule optimization.

Founded by scientists, CMD Bioscience stands ready to assist the pharmaceutical, biotech and life sciences community in achieving their goals.

Other Information
Ownership: Private
CT Employees: 4
World Employees: 4